Table 3.
Tumor type | Integrins expressed | Major associated consequence | Reference |
---|---|---|---|
LCBMa) | αvβ6 and αvβ3 | High expression in endothelial cells, low expression in tumor cells | [85] |
Prostate | αvβ3 and αvβ5 | High expression in peri-tumoral tissue depending on differentiation | [86] |
Breast | α6β4 and αvβ3 | Correlated with increased tumor size and grade and decreased survival (α6β4). Increased bone metastasis (αvβ3) | [87] |
Pancreatic | αvβ3 | Lymph node metastasis | [88] |
Glioblastoma | αvβ3 and αvβ5 | Both expressed at the tumor-normal tissue margin with a possible role in invasion | [89] |
Ovarian | α4β1 and αvβ3 | Increased peritoneal metastasis (α4β1) and tumor proliferation (αvβ3). | [90] |
Cervical | αvβ3 and αvβ6 | Decreased patient survival | [91] |
NSCLCb) | α5β1 | Decreased survival in patients with lymph node-negative tumors. | [92] |
Melanoma | αvβ3 and α5β1 | Vertical growth phase and lymph node metastasis | [93] |
Liver | αvβ6 | Differentiates cholangiocarcinoma from hepatocellular carcinoma | [94] |
Colon | αvβ6 | Reduced patient survival | [95] |
Lung cancer brain metastases;
Non-small-cell lung carcinoma.